Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. Mononuclear phagocytes - origins, fates and functions
- Prof. Steffen Jung
-
2. Transcription factors in macrophage differentiation
- Dr. Michael Sieweke
-
3. Fetal macrophages
- Prof. Paul Martin
-
4. The alveolar macrophage
- Dr. Ronald G. Crystal
-
5. Airway macrophages in health and disease
- Prof. Tracy Hussell
-
6. Intestinal macrophages - heterogeneity, origins and functions
- Prof. Allan Mowat
-
7. Osteoclasts: what do they do and how do they do it?
- Prof. Steven L. Teitelbaum
-
8. The biology of Fc receptors and complement receptors
- Prof. Steven Greenberg
-
10. Tumour-associated macrophages
- Prof. Michele De Palma
- Dr. Mario Squadrito
-
11. The recognition of pathogens by C-type lectins
- Prof. Gordon D. Brown
-
12. Macrophage phagocytosis
- Prof. Joel Swanson
-
13. Macrophage CD36 and atherosclerosis
- Dr. Maria Febbraio
-
14. Toll-Like receptor signaling and the innate immune response
- Dr. Kate Fitzgerald
-
15. Innate immune receptors as mediators of systemic inflammation and pathogenesis of malaria
- Prof. Ricardo Gazzinelli
-
17. Triggering receptors expressed on myeloid cells (TREM)
- Dr. Daniel W. McVicar
-
18. Influence of eicosanoid lipid mediators on macrophage innate immune functions
- Prof. Marc Peters-Golden
-
19. Macrophage paired receptor interactions
- Prof. Neil Barclay
-
20. Macrophage heterogeneity in atherosclerosis regression
- Prof. Edward Fisher
-
21. Gaucher disease: from lysosomal storage to immunopathology
- Prof. Johannes M.F.G. Aerts
-
22. Macrophage in asthma
- Prof. Douglas Robinson
-
23. The macrophage mannose receptor
- Dr. Luisa Martinez-Pomares
-
24. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
25. EGF-TM7 receptors
- Dr. Jörg Hamann
- Dr. Hsi-Hsien Lin
-
26. Macrophages in helminth infection
- Prof. Judith Allen
- Archived Lectures *These may not cover the latest advances in the field
-
27. Immunosuppressive mechanisms in myeloid cells
- Prof. Dmitry Gabrilovich
Printable Handouts
Navigable Slide Index
- Introduction
- Osteoblasts and osteoclasts
- Osteoclasts (1)
- Osteoporosis (1)
- Osteoporosis (2)
- Bone remodeling (1)
- Bone remodeling (2)
- Bone remodeling (3)
- Bone remodeling (4)
- Osteoporosis (3)
- Osteopetrosis
- Osteopetrosis X-ray
- Increased bone mass and osteopetrosis
- Clinical forms of osteopetrosis
- Malignant osteopetrosis
- A patient with osteopetrosis
- Transplantation result
- Patient at the age of 3
- Patient at adulthood
- What is the osteoclast precursor?
- Hematopoietic precursor or stromal cell origin?
- Y-chromosome
- Y-body analysis of osteoclasts and osteoblasts
- The osteoclast precursor
- Osteoclast differentiation (1)
- Osteoprotogerin
- Osteoclast differentiation (2)
- RANK ligand gene deletion
- Osteoclast differentiation (3)
- Osteoclasts generated in vitro
- Osteoclastogenic signals
- Osteoclast differentiation and function (1)
- How does the osteoclast degrade bone?
- Isolated micro-environment formation
- Osteoclast proton pump
- Osteoclast proton pump mutation
- Osteoclast differentiation and function (2)
- Carbonic anhydrase
- Family with benign osteopetrosis
- Carbonic anhydrase deficiency
- Osteoclast differentiation and function (3)
- Osteoclast PH changes
- In the presence of Cl-
- Cl-/HCO3- exchange (1)
- Cl-/HCO3- exchange (2)
- SLC4A2- anion exchanger
- Osteoclast differentiation and function (4)
- Anion access
- Osteoclast chloride channel
- Bone resorption mechanism
- Chloride channel and osteopetrosis
- Osteoclast differentiation and function (5)
- Bone = mineral + organic matrix
- Organic matrix degrading enzyme
- Cathepsin K
- Pyknodysostosis
- Osteoclast differentiation and function (6)
- Osteoclast-bone attachment mechanism
- Integrin-matrix attachment (1)
- Integrin family
- Beta3-/- mice are osteopetrotic (1)
- Beta3-/- mice are osteopetrotic (2)
- The effect of integrin deletion on osteoclasts
- Osteoclast cytoskeleton
- Podosome
- Actin ring
- Osteoclast E/M
- Clues to the formation of the ruffled border (1)
- Clues to the formation of the ruffled border (2)
- Formation of the ruffled border-mechanism
- Synaptotagmins (Syt)
- Does SytVII organize the ruffled border?
- SytVII-/- osteoclasts have abnormal ruffled border
- SytVII-/- osteoclasts resorb bone poorly
- Integrin-matrix attachment (2)
- Integrin organizes the osteoclast cytoskeleton
- Summary
- Osteoclast differentiation and function (7)
Topics Covered
- Osteoclast
- Osteoporosis
- Bone remodeling
- Osteopetrosis
- Mechanisms of osteoclast formation
- Mechanisms of osteoclastic bone resorption
- Osteoclast cytoskeleton
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Teitelbaum, S.L. (2012, May 8). Osteoclasts: what do they do and how do they do it? [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/NVQU7046.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Steven L. Teitelbaum has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.